Astrana Health/$ASTH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Astrana Health
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Ticker
$ASTH
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
1,900
ISIN
US03763A2078
Website
Astrana Health Metrics
BasicAdvanced
$1.2B
33.21
$0.73
1.00
-
Price and volume
Market cap
$1.2B
Beta
1
52-week high
$61.38
52-week low
$23.12
Average daily volume
272K
Financial strength
Current ratio
1.698
Quick ratio
1.632
Long term debt to equity
83.715
Total debt to equity
87.183
Dividend payout ratio (TTM)
15.58%
Interest coverage (TTM)
2.43%
Profitability
EBITDA (TTM)
109.474
Gross margin (TTM)
11.94%
Net profit margin (TTM)
1.56%
Operating margin (TTM)
3.55%
Effective tax rate (TTM)
40.84%
Revenue per employee (TTM)
$1,180,000
Management effectiveness
Return on assets (TTM)
3.90%
Return on equity (TTM)
8.10%
Valuation
Price to earnings (TTM)
33.211
Price to revenue (TTM)
0.516
Price to book
1.6
Price to tangible book (TTM)
5.48
Price to free cash flow (TTM)
22.15
Free cash flow yield (TTM)
4.51%
Free cash flow per share (TTM)
109.53%
Growth
Revenue change (TTM)
54.81%
Earnings per share change (TTM)
-44.65%
3-year revenue growth (CAGR)
37.75%
3-year earnings per share growth (CAGR)
-21.60%
What the Analysts think about Astrana Health
Analyst ratings (Buy, Hold, Sell) for Astrana Health stock.
Bulls say / Bears say
Astrana Health's revenue surged by 53% year-over-year to $620.4 million in Q1 2025, indicating strong growth momentum. (stocktitan.net)
The company's strategic acquisition of Collaborative Health Systems for $37.5 million is expected to enhance its provider network and care delivery capabilities. (stocktitan.net)
Analysts have raised Astrana Health's price target to $70.00, reflecting confidence in the company's growth potential. (marketbeat.com)
Despite revenue growth, Astrana Health reported a net loss of $7.0 million in Q4 2024, compared to income of $12.4 million in the same period last year. (stocktitan.net)
The company's operating margin declined to 3.3% in Q1 2025 from 7.5% in the same quarter last year, indicating increased operational costs. (stockstory.org)
Truist Financial lowered its price target for Astrana Health from $50.00 to $46.00, suggesting potential concerns about the company's future performance. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Astrana Health Financial Performance
Revenues and expenses
Astrana Health Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Astrana Health stock?
Astrana Health (ASTH) has a market cap of $1.2B as of June 20, 2025.
What is the P/E ratio for Astrana Health stock?
The price to earnings (P/E) ratio for Astrana Health (ASTH) stock is 33.21 as of June 20, 2025.
Does Astrana Health stock pay dividends?
No, Astrana Health (ASTH) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Astrana Health dividend payment date?
Astrana Health (ASTH) stock does not pay dividends to its shareholders.
What is the beta indicator for Astrana Health?
Astrana Health (ASTH) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.